Amarin Corp. (AMRN) – Corporate News
-
Sarissa Capital Believes Amarin (AMRN) Stock Is Meaningfully Undervalued, Increases Its Ownership
-
Catalyst Pharmaceuticals (CPRX) Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AMRN Stock Lookup